Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

O-074 Whole genome amplification (WGA) of blastocoelic fluid (BF) as an additional criterion for the selection of the most viable embryo

Title: O-074 Whole genome amplification (WGA) of blastocoelic fluid (BF) as an additional criterion for the selection of the most viable embryo
Authors: Albanese, C; Magli, M C; Perruzza, D; Terzuoli, G; Azzena, S; Crippa, A; Tabanelli, C; Gianaroli, L
Source: Human Reproduction ; volume 37, issue Supplement_1 ; ISSN 0268-1161 1460-2350
Publisher Information: Oxford University Press (OUP)
Publication Year: 2022
Description: Study question Is the presence or absence of DNA in the blastocoelic fluid detected by whole genomic amplification (WGA) a valid method to prioritize embryos for transfer? Summary answer Blastocysts with DNA in the BF have lower ongoing pregnancy rates compared with blastocysts without DNA, both in PGT-A and in conventional IVF cycles What is known already The detection of DNA in BFs from expanded blastocysts has been reported in different studies. After amplification, this DNA can be analyzed to provide information on the blastocyst chromosome condition, but the degree to which it is representative of the corresponding embryo ploidy is still controversial. The reason of this divergence could reside in several factors, including the different status of the studied embryos. A recent study comparing euploid and aneuploid blastocysts reported a significantly higher incidence of failed BF-DNA amplification in euploid blastocysts compared with aneuploid blastocysts suggesting an effect of the embryo ploidy condition on BF content Study design, size, duration This prospective study included 142 cycles with PGT-A (Group-1; 24-chromosome analysis was performed on trophectoderm (TE) biopsies) and 121 conventional IVF consecutive cycles (Group-2) treated in the last three years. In both groups, the BF was collected from expanded blastocysts before vitrification, and submitted to WGA. Single blastocyst transfers were performed by selecting blastocysts based on BF-WGA results giving priority to those with failed amplification. In Group-1, only TE-euploid blastocysts were transferred Participants/materials, setting, methods Patients in Group-1 had a maternal age higher than in Group-2 (36.8±3 vs 34.1±3.5 years). The same protocol of vitrification was used for all patients, and only expanded blastocysts of high grade were included in the study. Amplification after WGA was evaluated by loading an aliquot of the amplified product onto a 1.5% agarose gel. An ongoing pregnancy was defined as a pregnancy regularly ongoing ...
Document Type: article in journal/newspaper
Language: English
DOI: 10.1093/humrep/deac104.088
Availability: https://doi.org/10.1093/humrep/deac104.088; https://academic.oup.com/humrep/article-pdf/37/Supplement_1/deac104.088/44305779/deac104.088.pdf
Rights: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
Accession Number: edsbas.6BF79E2
Database: BASE